EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The costs of diagnosing and treating skin cancer: Findings from the QSkin Study

Daniel Lindsay, Louisa G Collins, Catherine M Olsen, Nirmala Pandeya, David C Whiteman

Australian and New Zealand Journal of Public Health · 2026-08 · 50 (4) · 100326

DOI: 10.1016/j.anzjph.2026.100326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Public Health, 2026-08. Verfasst von Daniel Lindsay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia; Population Health Department, QIMR Berghofer Medical Rese…. Hauptthemen laut MEDLINE: Skin Neoplasms, Health Care Costs, Health Expenditures. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To estimate the proportion of all healthcare expenses attributable to diagnosing and managing skin cancer in a large, population-based cohort, and identify characteristics of high users of skin cancer services. METHODS: A prospective cohort study of 40,338 Queensland residents with linked healthcare data from the Medical Benefits Scheme (MBS), Pharmaceutical Benefits Scheme (PBS) and Queensland Hospital Admitted Patient Data Collection databases. We quantified the frequency of use and healthcare costs (out-of-pocket and government) for MBS services, PBS services and hospital admissions related to skin cancer. RESULTS: Over an average of 8.5 years follow-up, 71% (n=28,498) of participants used 245,919 skin cancer services, costing the government approximately $43.1 million (2.4% of all health service costs). In total, 51% (n=20,548) of participants had ≥1 skin biopsy, 36% (n=14,458) had ≥1 keratinocyte cancer excision and 8% (n=3,226) had hospital admissions. Out of the total government or out-of-pocket costs for skin cancer services, 44% and 41% were for keratinocyte cancer excisions, respectively. CONCLUSIONS: Services for diagnosing and treating skin cancer accounted for 2.4% of all direct health service costs in this Queensland cohort. IMPLICATIONS FOR PUBLIC HEALTH: As skin cancer is largely preventable, investing in enhanced primary prevention efforts may mitigate these significant burdens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsHealth Care CostsHealth ExpendituresHumansFemaleMaleQueenslandMiddle AgedProspective StudiesAgedAdultAged, 80 and overHospitalizationNon-Melanoma Skin Neoplasms

Stichwörter der Autor:innen

economic burdenhealth serviceskeratinocyte carcinomamelanomaprimary prevention

Autor:innen und Institutionen

  • Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Faculty of Health, Me…
  • Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Cancer and Palliative…
  • Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; The Frazer Institute, The University of Queensland, Brisbane, Queensland, Australia.
  • Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Faculty of Health, Medicine, and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Lindsay, D., Collins, L. G., Olsen, C. M., Pandeya, N., & Whiteman, D. C. (2026). The costs of diagnosing and treating skin cancer: Findings from the QSkin Study. Australian and New Zealand Journal of Public Health, 50(4), 100326. https://doi.org/10.1016/j.anzjph.2026.100326

Vancouver

Lindsay D, Collins LG, Olsen CM, Pandeya N, Whiteman DC. The costs of diagnosing and treating skin cancer: Findings from the QSkin Study. Australian and New Zealand Journal of Public Health. 2026;50(4):100326. doi:10.1016/j.anzjph.2026.100326

BibTeX
@article{Lindsay2026,
  author = {Lindsay, Daniel and Collins, Louisa G and Olsen, Catherine M and Pandeya, Nirmala and Whiteman, David C},
  title = {The costs of diagnosing and treating skin cancer: Findings from the QSkin Study},
  journal = {Australian and New Zealand Journal of Public Health},
  year = {2026},
  volume = {50},
  number = {4},
  pages = {100326},
  doi = {10.1016/j.anzjph.2026.100326}
}
Kostenlos starten →